Abstract
We report the clinical research of a new antibacterial combination (Gantanol+ trimethoprim; F. Hoffmann-La Roche & Co. Ltd.) in the management of chronic urinary tract infections.
The combination Ro 6-2580/4 administered to 51 patients with and without G.U. obstructions ended up with 55 per cent. good results following. Kass criteria whereas the Ro 6-2580/9-11 in 32 patients without obstruction that rate increased up to the 75 per cent. of cases.
Few adverse reactions were noted.
Similar content being viewed by others
Article PDF
References
Csonka, B W & Knight, G J (1967). Brit. J. Vener. Dis. 43, 161.
Darrell, J et al. (1968). J. Clin. Pathol. 21, 202.
Leading article (1968). Brit. Med. J. 2, 380.
Roth, B et al. (1962). J. Med. Pharm. Chem. 5, 1103.
Sourander, L B & Werner, G (1967). Efficacy and tolerance of sulphonamide + trimethoprim combinations in geriatric patients with bacteriuria. Vth. Int. Congr. Chemoth., Vienna, June 26th.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bernstein-Hahn, L. Chemotherapy in chronic urinary tract infection. Spinal Cord 7, 96–101 (1969). https://doi.org/10.1038/sc.1969.17
Issue Date:
DOI: https://doi.org/10.1038/sc.1969.17